Skip to main content
TGTX
NASDAQ Life Sciences

TG Therapeutics Posts 35c Q3 EPS as BRIUMVI Momentum Builds

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$58.11
Mkt Cap
$9.157B
52W Low
$26.76
52W High
$63.6
52W Position info
117% above low
Off High info
8.6% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

TGTX has more than doubled off its 52-week low of $26.76.

Summary

TG Therapeutics reported third-quarter EPS of 35 cents, per Dow Jones, on third-quarter revenue of $259.9M. That follows a strong second quarter in which BRIUMVI U.S. revenue hit $227.7M, up 64% year over year, and management raised full-year guidance to roughly $950M. The company has now raised its 2026 revenue guidance again, targeting over $1.0B. It also carries a $300M expanded buyback and $500M of non-dilutive capital secured earlier this year, so profitability at this level is a meaningful step for a commercial-stage biotech.

At the time of this announcement, TGTX was trading at $58.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.2B. The 52-week trading range was $26.76 to $63.60. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

TGTX - Latest Insights

TGTX
Nov 09, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $63.00
Real-time Price: $61.97 info
Change: -$1.03 (-2%) info
Market Cap: $9.157B info
TGTX
Oct 23, 2026, 11:03 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $52.44
Real-time Price: $61.97 info
Change: +$9.53 (+18%) info
Market Cap: $9.157B info
TGTX
Aug 05, 2026, 5:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $50.48
Real-time Price: $61.97 info
Change: +$11.49 (+23%) info
Market Cap: $9.157B info
TGTX
Aug 03, 2026, 9:22 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $51.30
Real-time Price: $61.97 info
Change: +$10.67 (+21%) info
Market Cap: $9.157B info
TGTX
Aug 03, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $50.77
Real-time Price: $61.97 info
Change: +$11.20 (+22%) info
Market Cap: $9.157B info